METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS
First Claim
1. A method of treating a skin condition comprising topically applying to skin in need thereof a composition comprising 4-methyl-3-decen-5-ol, 3,3-dimethyl-5(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, a mixture comprising 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)ethan-1-one, 1-(2,3,8,8-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone, and 1-(2,3,8,8-tetramethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)ethanone, 2,6-dimethyl-5-heptenal, 3-hexen-1-ol, or (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one.
0 Assignments
0 Petitions
Accused Products
Abstract
A method for treating skin, reducing oxidative damage to a skin cell, reducing lipoxygenase (LO) activity in a skin cell, reducing cyclooxygenase (COX) activity in a skin cell, reducing tumor necrosis factor alpha (TNF-α) in a skin cell, or reduction matrix metalloproteinase enzyme activity in a skin cell comprising contacting skin or a skin cell with an aromatic skin-active ingredient.
-
Citations
22 Claims
- 1. A method of treating a skin condition comprising topically applying to skin in need thereof a composition comprising 4-methyl-3-decen-5-ol, 3,3-dimethyl-5(2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, a mixture comprising 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)ethan-1-one, 1-(2,3,8,8-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone, and 1-(2,3,8,8-tetramethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)ethanone, 2,6-dimethyl-5-heptenal, 3-hexen-1-ol, or (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one.
- 12. A method of treating a fine line or wrinkle comprising topically applying to a fine line or wrinkle on skin a composition comprising 3-hexen-1-ol, 4-methyl-3-decen-5-ol, or (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one, wherein MMP-9 activity is reduced in a skin cell of the skin.
- 17. A method of reducing skin inflammation comprising topically applying to inflamed skin a composition comprising 3-hexen-1-ol, 3,3-dimethyl-5 (2,2,3-trimethyl-3-cyclopenten-1-yl)-4-penten-2-ol, 2,6-dimethyl-5-heptenal, or a mixture comprising 1-(1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)ethan-1-one, 1-(2,3,8,8-tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone, and 1-(2,3,8,8-tetramethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen-2-yl)ethanone, wherein COX-2 activity or lipoxygenase activity is reduced in a skin cell of the skin.
Specification